Andrés Caballero1, Wenbin Mao1, Raymond McKay2, Wei Sun1. 1. Tissue Mechanics Laboratory, The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA. 2. Division of Cardiology, The Hartford Hospital, Hartford, Connecticut, USA.
Abstract
BACKGROUND: Mitral regurgitation (MR) is present in a large proportion of patients who undergo transcatheter aortic valve replacement (TAVR). However, existing clinical data on the impact of TAVR on early post-procedural MR severity are contradictory. Using a comprehensive computational engineering methodology, this study aimed to evaluate quantitatively the structural and hemodynamic impact of TAVR on aortic-mitral continuity and MR severity in a rigorously developed and validated patient-specific left heart (LH) computer model with aortic stenosis and concomitant functional MR. METHODS: TAVR procedure was virtually simulated using a self-expandable valve (SEV) at three implantation heights. Pre- and post-TAVR LH dynamics as well as intra-operative biomechanics were analyzed. RESULTS: No significant differences in early MR improvement (<10%) were noted at the three implantation depths when compared to the pre-TAVR state. The high deployment model resulted in the highest stress in the native aortic leaflets, lowest stent-tissue contact force, highest aortic-mitral angle, and highest MR reduction for this patient case. When comparing SEV vs. balloon-expandable valve (BEV) performance at an optimal implantation height, the SEV gave a higher regurgitant volume ⋅ than the pre-TAVR model (40.49 vs 37.59 ml), while the BEV model gave the lowest regurgitant volume (33.84 vs 37.59 ml). CONCLUSIONS: Contact force, aortic-mitral angle, and valve annuli compression were identified as possible mechanistic parameters that may suggest avenues for acute MR improvement. Albeit a single patient parametric study, it is our hope that such detailed engineering analysis could shed some light into the underlying biomechanical mechanisms of TAVR impact on MR.
BACKGROUND: Mitral regurgitation (MR) is present in a large proportion of patients who undergo transcatheter aortic valve replacement (TAVR). However, existing clinical data on the impact of TAVR on early post-procedural MR severity are contradictory. Using a comprehensive computational engineering methodology, this study aimed to evaluate quantitatively the structural and hemodynamic impact of TAVR on aortic-mitral continuity and MR severity in a rigorously developed and validated patient-specific left heart (LH) computer model with aortic stenosis and concomitant functional MR. METHODS: TAVR procedure was virtually simulated using a self-expandable valve (SEV) at three implantation heights. Pre- and post-TAVR LH dynamics as well as intra-operative biomechanics were analyzed. RESULTS: No significant differences in early MR improvement (<10%) were noted at the three implantation depths when compared to the pre-TAVR state. The high deployment model resulted in the highest stress in the native aortic leaflets, lowest stent-tissue contact force, highest aortic-mitral angle, and highest MR reduction for this patient case. When comparing SEV vs. balloon-expandable valve (BEV) performance at an optimal implantation height, the SEV gave a higher regurgitant volume ⋅ than the pre-TAVR model (40.49 vs 37.59 ml), while the BEV model gave the lowest regurgitant volume (33.84 vs 37.59 ml). CONCLUSIONS: Contact force, aortic-mitral angle, and valve annuli compression were identified as possible mechanistic parameters that may suggest avenues for acute MR improvement. Albeit a single patient parametric study, it is our hope that such detailed engineering analysis could shed some light into the underlying biomechanical mechanisms of TAVR impact on MR.
Authors: William A Zoghbi; Maurice Enriquez-Sarano; Elyse Foster; Paul A Grayburn; Carol D Kraft; Robert A Levine; Petros Nihoyannopoulos; Catherine M Otto; Miguel A Quinones; Harry Rakowski; William J Stewart; Alan Waggoner; Neil J Weissman Journal: J Am Soc Echocardiogr Date: 2003-07 Impact factor: 5.251
Authors: Anna S Petronio; Jan-Malte Sinning; Nicolas Van Mieghem; Giulio Zucchelli; Georg Nickenig; Raffi Bekeredjian; Johan Bosmans; Francesco Bedogni; Marian Branny; Karl Stangl; Jan Kovac; Molly Schiltgen; Stacia Kraus; Peter de Jaegere Journal: JACC Cardiovasc Interv Date: 2015-05 Impact factor: 11.195
Authors: Mathieu Vergnat; Melissa M Levack; Benjamin M Jackson; Joseph E Bavaria; Howard C Herrmann; Albert T Cheung; Stuart J Weiss; Joseph H Gorman; Robert C Gorman Journal: Ann Thorac Surg Date: 2012-12-13 Impact factor: 4.330
Authors: Apostolos Tzikas; Nicolo Piazza; Bas M van Dalen; Carl Schultz; Marcel L Geleijnse; Robert-Jan van Geuns; Tjebbe W Galema; Rutger-Jan Nuis; Amber Otten; Juan-Luis Gutierrez-Chico; Patrick W Serruys; Peter P de Jaegere Journal: Catheter Cardiovasc Interv Date: 2010-01-01 Impact factor: 2.692